2025年1月24日 · Discover how Astellas is shaping the future of healthcare through strategic partnerships that drive scientific innovation and deliver transformative therapies to patients. View more

Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company

Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd ...

Developing innovative therapies is one of the most challenging, most essential and personally rewarding fields in science. Everything we do is led by our company values of integrity, being patient centric, taking ownership, delivering results and communicating openly. These values are essential to Astellas’ relationship with its employees.

Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.

1 天前 · Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the following changes to its management structure effective April 1, 2025.

Astellas strives to address the unmet medical needs of patients by creating innovative pharmaceutical products. Astellas Pharma U.S., Inc. is committed to providing patients, customers, communities and employees with a bright future... Learn more about Astellas leaders.

Astellas' VISION, "on the forefront of healthcare change to turn innovative science into VALUE for patients," drives our pursuit of innovative healthcare solutions. In order to deliver significant VALUE to society, Astellas maintains a high ratio of R&D expenses to revenue (18.3%) and will continue to make necessary investments for further growth.

1 天前 · TOKYO, February 4, 2025 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the following changes to its management structure effective April 1, 2025.. Regarding the Changes in Management Structure Astellas aims to create and deliver "VALUE" for patients. To promote drug discovery activities swiftly and efficiently …

Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world. At Astellas, we strive to be a cutting-edge, value-driven life science innovator....